Rosiglitazone is a safe and effective treatment option of new-onset diabetes mellitus after renal transplantation
Year: 2005
Type: article
Study design: Clinical Trial
Source: Transplant International
Institution: Essen University Hospital
Language: English
Subfield: Transplantation
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2047250310
